PharMetrics Plus, enhanced with U.S. mortality data, offers unmatched real-world evidence for HEOR and commercial analytics. Covering over 210 million enrollees with 90% mortality capture compared to CDC data, it supports survival analyses, cost of care at end-of-life, and comparative effectiveness studies. Researchers can link to EMR, labs, biomarkers, and consumer datasets for deeper insights across the product lifecycle—from early development through commercialization. Delivered in OMOP or cloud formats, it ensures transparency and third-party access. By integrating mortality outcomes with claims and treatment data, it provides a holistic view of patient journeys and healthcare impact.

Join for free to read